Arcadia Biosciences (RKDA) Misses Q3 EPS by 4c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.11), $0.04 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Gartner places F5 in AI application security emerging market report
• Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)